167 related articles for article (PubMed ID: 27097498)
1. [Progress in researches on macrophages in liver fibrosis of schistosomiasis].
Xie YY; Xu YH; Chu DY; Shen JL
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2015 Dec; 27(6):669-73. PubMed ID: 27097498
[TBL] [Abstract][Full Text] [Related]
2. The innate immune receptor TREM-1 promotes liver injury and fibrosis.
Nguyen-Lefebvre AT; Ajith A; Portik-Dobos V; Horuzsko DD; Arbab AS; Dzutsev A; Sadek R; Trinchieri G; Horuzsko A
J Clin Invest; 2018 Nov; 128(11):4870-4883. PubMed ID: 30137027
[TBL] [Abstract][Full Text] [Related]
3. Schistosome-Induced Fibrotic Disease: The Role of Hepatic Stellate Cells.
Carson JP; Ramm GA; Robinson MW; McManus DP; Gobert GN
Trends Parasitol; 2018 Jun; 34(6):524-540. PubMed ID: 29526403
[TBL] [Abstract][Full Text] [Related]
4. Liver inflammation and fibrosis.
Koyama Y; Brenner DA
J Clin Invest; 2017 Jan; 127(1):55-64. PubMed ID: 28045404
[TBL] [Abstract][Full Text] [Related]
5. Cytokine regulation of hepatic stellate cells in liver fibrosis.
Tsukamoto H
Alcohol Clin Exp Res; 1999 May; 23(5):911-6. PubMed ID: 10371413
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of hepatic stellate cells, collagen types I and III synthesis and gene expression of selected cytokines during hepatic fibrogenesis following Mesocestoides vogae (Cestoda) infection in mice.
Hrckova G; Velebný S; Solár P
Int J Parasitol; 2010 Feb; 40(2):163-74. PubMed ID: 19631650
[TBL] [Abstract][Full Text] [Related]
7. Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend?
Yi HS; Jeong WI
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():99-104. PubMed ID: 23855303
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3, histone deacetylases, and Hedgehog signaling: Possible convergent targets in schistosomiasis-induced liver fibrosis.
de Oliveira FL; Carneiro K; Brito JM; Cabanel M; Pereira JX; Paiva LA; Syn W; Henderson NC; El-Cheikh MC
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005137. PubMed ID: 28231240
[TBL] [Abstract][Full Text] [Related]
9. Macrophage Phenotype in Liver Injury and Repair.
Sun YY; Li XF; Meng XM; Huang C; Zhang L; Li J
Scand J Immunol; 2017 Mar; 85(3):166-174. PubMed ID: 27491503
[TBL] [Abstract][Full Text] [Related]
10. Macrophage in liver Fibrosis: Identities and mechanisms.
Wang Z; Du K; Jin N; Tang B; Zhang W
Int Immunopharmacol; 2023 Jul; 120():110357. PubMed ID: 37224653
[TBL] [Abstract][Full Text] [Related]
11. Role of Kupffer Cells in Driving Hepatic Inflammation and Fibrosis in HIV Infection.
Zhang L; Bansal MB
Front Immunol; 2020; 11():1086. PubMed ID: 32612603
[TBL] [Abstract][Full Text] [Related]
12. [The roles of Kupffer cells in the development and regression of liver fibrosis].
Wu JY; Liu GT
Yao Xue Xue Bao; 2008 Sep; 43(9):884-9. PubMed ID: 19048777
[TBL] [Abstract][Full Text] [Related]
13. Stellate cell activation in alcoholic fibrosis--an overview.
Friedman SL
Alcohol Clin Exp Res; 1999 May; 23(5):904-10. PubMed ID: 10371412
[TBL] [Abstract][Full Text] [Related]
14. Liver fibrosis: mechanisms of immune-mediated liver injury.
Xu R; Zhang Z; Wang FS
Cell Mol Immunol; 2012 Jul; 9(4):296-301. PubMed ID: 22157623
[TBL] [Abstract][Full Text] [Related]
15. Targeting hepatic macrophages to treat liver diseases.
Tacke F
J Hepatol; 2017 Jun; 66(6):1300-1312. PubMed ID: 28267621
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of prostaglandin E1 on activation of hepatic stellate cells in rabbits with schistosomiasis.
Zou WL; Yang Z; Zang YJ; Li DJ; Liang ZP; Shen ZY
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):176-81. PubMed ID: 17374578
[TBL] [Abstract][Full Text] [Related]
17. Interplay Between Macrophages and Angiogenesis: A Double-Edged Sword in Liver Disease.
Ramirez-Pedraza M; Fernández M
Front Immunol; 2019; 10():2882. PubMed ID: 31921146
[TBL] [Abstract][Full Text] [Related]
18. Liver fibrosis - mouse models and relevance in human liver diseases.
Mederacke I
Z Gastroenterol; 2013 Jan; 51(1):55-62. PubMed ID: 23315652
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C.
Wu LY; Liu S; Liu Y; Guo C; Li H; Li W; Jin X; Zhang K; Zhao P; Wei L; Zhao J
Clin Immunol; 2015 May; 158(1):77-87. PubMed ID: 25771172
[TBL] [Abstract][Full Text] [Related]
20. Strategies to prevent and reverse liver fibrosis in humans and laboratory animals.
Chen RJ; Wu HH; Wang YJ
Arch Toxicol; 2015 Oct; 89(10):1727-50. PubMed ID: 25963329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
